Series B funding round for Kailera Therapeutics raising $600M in October 2025
Series B funding round for Kailera Therapeutics raising $600M in October 2025
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Private | — | |
| Hedge Fund | — | |
| Private | — | |
| Venture Capital | — | |
| Government Office | — | |
| Venture Capital | — | |
| Public | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | gotham makker | |
| Angel | Michael Gladstone | |
| Angel | Sirona Capital |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$1B
Top Valuation
-
Kailera Therapeutics raised $600M in a Series B round.
The round was announced on 10/01/25.
The round was led by Andrew Kaplan.